pe
pep-05182 v1 CC-BY-SA-4.0

Glucagon blood sugar and appetite peptide

An experimental lab-made peptide that switches on the body's GLP-1 receptor, the same target as Ozempic, to help control blood sugar and curb hunger. Not an approved medicine.

statuscomputed targetGLP-1R length29 aa refs1
metabolic
EARLY ENTRY This candidate is newly indexed — supporting evidence is still being added. Have a paper or data point? Contribute below.
status 2 / 5 · 2 contributors
prediction metrics boltz-2 1.0
ipTM0.897
pTM0.844
avg pLDDT71.6
ranking score0.752
STRUCTURE · PEP-05182 × GLP-1R
ranking0.752
target interface 4.5Å peptide drag rotate · ctrl+scroll zoom · right-click pan
boltz-2 1.0 · mmCIF ↓ download
sequence29 aa
151015202529
HSQGTFTSDYSKHLD SRYAQEFVQWLMNT
in the news 136 articles
details expand to inspect
full evidence table2 metrics
metricvaluetool
ipTM 0.8971244692802429 boltz-2
ranking score 0.7524121403694153 boltz-2
structural qualityopenfold3
metricvaluenote
gpde0.834global PDE — lower = better
disorderNaNfraction disordered
3-letter notation
His-Ser-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Lys-His-Leu-Asp-Ser-Arg-Tyr-Ala-Gln-Glu-Phe-Val-Gln-Trp-Leu-Met-Asn-Thr
recipeboltz-2 1.0
parametervalue
modelboltz-2 1.0
weights
hardwarenvidia_nim_api
mlx version
python
random seed
msa strategynone
diffusion samples1
runtime
predicted bymlx@peptide
predicted at2026-04-24
citationbibtex
peptidemodel (2026). Glucagon blood sugar and appetite peptide (pep-05182, v1). PeptideModel. https://peptidemodel.com/card/pep-05182
@peptide{pep05182,
  sequence = {HSQGTFTSDYSKHLDSRYAQEFVQWLMNT},
  target   = {glp-1r},
  author   = {peptidemodel},
  year     = {2026},
  status   = {computed}
}
related peptides 5 by signal overlap
references 1 papers
[1] source scaffold
discussion no comments
sign in to comment
peptidemodel.com CC-BY-SA-4.0 research only · not for human use